Canada has authorised the use of the Pfizer/BioNTech Covid-19 vaccine for children aged 5-11.
Medical officials claimed such a move was timely, given that incidences of Covid-19 are now highest in that age bracket in Canada.
Health Canada said: “After a thorough and independent scientific review of the evidence, the department has determined that the benefits of this vaccine for children between five and 11 years of age outweigh the risks.”
The vaccine will be given in two doses of 10 micrograms, three weeks apart. Adult doses contain 30 micrograms.
Chief medical adviser to the federal health ministry Supriya Sharma said: “This authorisation comes at a critical time in the pandemic.”
“Over the course of the third and the fourth wave, incident rates have been increasing among children less than 12 years of age.”
IMAGE – Army Spc. Angel Laureano holds a vial of the COVID-19 vaccine, Walter Reed National Military Medical Center, Bethesda, Md., Dec. 14, 2020. (DoD photo by Lisa Ferdinando)